AZN - Spark Newswire

2 minute read

Uncategorized

Facebook Sees Paid Subscribers For Workplace Rise 40% But It Remains Far Behind Microsoft’s Teams

Today, 10:32 PM

Facebook Inc (NASDAQ: FB) said Tuesday the number of paid subscribers for its enterprise communication software Workplace has jumped 40% to reach 7 million subscribers, compared to a year ago.

AZN

5 minute read

Stock Wars: AstraZeneca Vs. Pfizer

By Phil Hall

Today, 10:32 PM

Benzinga’s Stock Wars series matches up two leaders in a major industry sector, with the goal of letting readers decide which company is the better investment.

ALXN

1 minute read

Uncategorized

‘White House plans to redistribute unordered vaccine supply, telling states: Use it or lose it’ -Washington Post

By Benzinga Newsdesk

Today, 10:32 PM

https://www.washingtonpost.com/health/2021/05/04/vaccine-distribution-biden/

AZN

3 minute read

Uncategorized

AstraZeneca’s Farxiga approved in the US for Chronic Kidney Disease

By Charles Gross

Today, 10:32 PM

AstraZeneca's (NYSE: AZN) Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the US to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (ESKD), cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults wi

AZN

2 minute read

Uncategorized

Price Over Earnings Overview: AstraZeneca

By Benzinga Insights

Today, 10:32 PM

AZN

1 minute read

Uncategorized

Moderna Inks Supply Pact Of 500M COVID-19 Vaccine Doses To COVAX Effort Starting Q4

By Vandana Singh

Today, 10:32 PM

Moderna Inc (NASDAQ: MRNA) has announced an agreement with vaccine promoter Gavi to supply up to 500 million doses of its COVID-19…

AZN

3 minute read

Uncategorized

Who Is — And Will Be — Making Money From COVID-19 Vaccines?

By Financialounge.com

Today, 10:32 PM

Schroders' Expert John Bowler Analyzes The Pharmaceutical Groups Involved In COVID-19 Drug Development, Emphasizing That Their Efforts Will Be Rewarded In The Future, Despite Current Low Benefits.

AZN